CD73-positive cells were shown diminished with CA, BM, CIS, and the combinations of CIS + CA and CIS + BM treatments in A375 and B16F10 melanoma cell lines when compared to the negative control group (Figure 7I). This evidence concerns the gene NT5E and in situ carcinoma.